A Paucity of Code Status Documentation Despite Increasing Complex Chronic Disease in Pediatrics

Katherine A Battisti1, Daniel M Cohen1, Tran Bourgeois2

  • 1Division of Emergency Medicine, Department of Pediatrics, The Ohio State University College of Medicine/Nationwide Children's Hospital, Columbus, Ohio, USA.

Insights

Code status discussions (CSDs) are infrequently documented in electronic health records for children with complex chronic diseases (CCDs). Improving CSD documentation is crucial for family-centered care in pediatric complex chronic diseases.

Area of Science:

  • Pediatric Healthcare
  • Medical Ethics
  • Health Informatics

Background:

  • Medical advances have increased the number of children with complex chronic diseases (CCDs).
  • Code status discussions (CSDs) are essential for these patients but show significant variability in frequency and documentation.
  • Gaps in CSD documentation within electronic health records (EHRs) require investigation.

Purpose of the Study:

  • To identify deficiencies in the documentation of code status discussions (CSDs) within the electronic health record (EHR).
  • To focus on pediatric patients with complex chronic diseases (CCDs).

Main Methods:

  • Retrospective review of pediatric patients admitted from the emergency department in 2016.
  • Utilized EHR query (Apache Hadoop cluster) and manual review to identify documented CSDs (orders, advance directives, provider notes).
  • Stratified patient complexity using the Pediatric Medical Complexity Algorithm 3.0 and performed comparative analysis.

Main Results:

  • Out of 12,648 patients, 4157 (32.9%) had CCDs; only 209 (1.7%) had documented CSDs, with 95.7% of those having CCDs.
  • Among 528 patients aged ≥18 years, 81.1% had CCDs, but only 12.3% had CSDs.
  • Palliative care consultation increased CSD odds (OR: 21.4), while African American race decreased them (OR: 0.42).

Conclusions:

  • Most admitted pediatric patients, including those with CCDs and older pediatric patients, lack documented CSDs.
  • Significant improvements are needed in the frequency and consistency of CSD documentation.
  • Enhanced CSD documentation is vital for effective family-centered care for children with CCDs.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
153
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
795
Methods of Documentation II: POMR01:26

Methods of Documentation II: POMR

The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
1.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
142
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
180
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
384